GALEW Stock DD Galena Biopharma, Inc. 07/21/2014 12:07:21
Post# of 250616
Posted On: 07/21/2014 1:07:11 PM
GALEW Galena Biopharma, Inc. $GALEW Company Overview
Stock Message Board http://investorshangout.com/search?q=GALEW&am...mp;yt1=Go!
Last Updated: 07/21/2014 12:07:16
Current Price and Quotes
Last Price 1.20
Previous Close 1.20 Open N/A
Daily Range N/A - N/A 52wk Range 0.445 - 4.90
Volume 0 Dividend N/A
Average Vol (3m) 21,022 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,487 - - -
Cost of Revenue 520 - - -
Gross Profit 1,967 - - -
Operating Expenses
Research and Development 21,076 14,614 3,851 6,046
Sales, General and Admin. 14,600 6,585 8,635 10,579
Non-Recurring Items - - - -
Other 131 - - -
Operating Income (33,840) (21,199) (12,486) (16,625)
Income From Continuing Operations
Add'l Income/Expense Items (40,979) (13,145) 9,086 4,632
Earnings Before Interest and Tax (75,626) (34,377) (3,407) (11,993)
Interest Expense - - - -
Earnings Before Tax (75,626) (34,377) (3,407) (11,993)
Income Tax 1,052 (1,052) - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (76,678) (33,325) (3,407) (11,993)
Non Recurring Events
Discontinued Operations - (1,644) (8,078) -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (76,678) (34,969) (11,485) (11,993)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (76,678) (34,969) (11,485) (11,993)
Recent News
Jul 4, 2014 Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma
Jul 1, 2014 Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S)
Jun 26, 2014 Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma
Jun 26, 2014 New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell
Jun 19, 2014 Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 17, 2014 Galena Biopharma Recent Events will Continue to Weigh In on Shares, Analyst Report by BrokerBank Securities, Inc.
Jun 17, 2014 Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers
Jun 16, 2014 Theralase's Cancer Technology Demonstrates Vaccine-Like Properties
Jun 12, 2014 Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos
Jun 2, 2014 Galena Biopharma Presents GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting
1
2
3
next >
GALEW Galena Biopharma, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GALEW&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GALEW/quote
Stock Chart http://www.otcmarkets.com/stock/GALEW/chart
Company Info http://www.otcmarkets.com/stock/GALEW/company-info
Recent News http://www.otcmarkets.com/stock/GALEW/news
Financials http://www.otcmarkets.com/stock/GALEW/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GALEW/filings
Short Sales http://www.otcmarkets.com/stock/GALEW/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GALEW/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GALEW/research
Summary http://finance.yahoo.com/q?s=GALEW
Historical Prices http://finance.yahoo.com/q/hp?s=GALEW+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GALEW
Basic Chart http://finance.yahoo.com/q/bc?s=GALEW+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GALEW+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GALEW+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GALEW+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GALEW+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GALEW+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GALEW+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GALEW+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GALEW+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GALEW+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GALEW
Balance Sheet http://finance.yahoo.com/q/bs?s=GALEW
Cash Flow http://finance.yahoo.com/q/cf?s=GALEW+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GALEW
Market Watch http://www.marketwatch.com/investing/stock/GALEW
Bloomberg http://www.bloomberg.com/quote/GALEW:US
Morningstar http://quotes.morningstar.com/stock/s?t=GALEW
Bussinessweek http://investing.businessweek.com/research/st...cker=GALEW
Barchart http://www.barchart.com/quotes/stocks/GALEW
OTC Short Report http://otcshortreport.com/index.php?index=GALEW
Investopedia http://www.investopedia.com/markets/stocks/GALEW/?wa=0
Stock Message Board http://investorshangout.com/search?q=GALEW&am...mp;yt1=Go!
Last Updated: 07/21/2014 12:07:16
Current Price and Quotes
Last Price 1.20
Previous Close 1.20 Open N/A
Daily Range N/A - N/A 52wk Range 0.445 - 4.90
Volume 0 Dividend N/A
Average Vol (3m) 21,022 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,487 - - -
Cost of Revenue 520 - - -
Gross Profit 1,967 - - -
Operating Expenses
Research and Development 21,076 14,614 3,851 6,046
Sales, General and Admin. 14,600 6,585 8,635 10,579
Non-Recurring Items - - - -
Other 131 - - -
Operating Income (33,840) (21,199) (12,486) (16,625)
Income From Continuing Operations
Add'l Income/Expense Items (40,979) (13,145) 9,086 4,632
Earnings Before Interest and Tax (75,626) (34,377) (3,407) (11,993)
Interest Expense - - - -
Earnings Before Tax (75,626) (34,377) (3,407) (11,993)
Income Tax 1,052 (1,052) - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (76,678) (33,325) (3,407) (11,993)
Non Recurring Events
Discontinued Operations - (1,644) (8,078) -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (76,678) (34,969) (11,485) (11,993)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (76,678) (34,969) (11,485) (11,993)
Recent News
Jul 4, 2014 Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma
Jul 1, 2014 Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S)
Jun 26, 2014 Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma
Jun 26, 2014 New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell
Jun 19, 2014 Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 17, 2014 Galena Biopharma Recent Events will Continue to Weigh In on Shares, Analyst Report by BrokerBank Securities, Inc.
Jun 17, 2014 Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers
Jun 16, 2014 Theralase's Cancer Technology Demonstrates Vaccine-Like Properties
Jun 12, 2014 Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos
Jun 2, 2014 Galena Biopharma Presents GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting
1
2
3
next >
GALEW Galena Biopharma, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GALEW&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GALEW/quote
Stock Chart http://www.otcmarkets.com/stock/GALEW/chart
Company Info http://www.otcmarkets.com/stock/GALEW/company-info
Recent News http://www.otcmarkets.com/stock/GALEW/news
Financials http://www.otcmarkets.com/stock/GALEW/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GALEW/filings
Short Sales http://www.otcmarkets.com/stock/GALEW/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GALEW/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GALEW/research
Summary http://finance.yahoo.com/q?s=GALEW
Historical Prices http://finance.yahoo.com/q/hp?s=GALEW+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GALEW
Basic Chart http://finance.yahoo.com/q/bc?s=GALEW+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GALEW+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GALEW+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GALEW+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GALEW+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GALEW+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GALEW+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GALEW+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GALEW+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GALEW+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GALEW
Balance Sheet http://finance.yahoo.com/q/bs?s=GALEW
Cash Flow http://finance.yahoo.com/q/cf?s=GALEW+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GALEW
Market Watch http://www.marketwatch.com/investing/stock/GALEW
Bloomberg http://www.bloomberg.com/quote/GALEW:US
Morningstar http://quotes.morningstar.com/stock/s?t=GALEW
Bussinessweek http://investing.businessweek.com/research/st...cker=GALEW
Barchart http://www.barchart.com/quotes/stocks/GALEW
OTC Short Report http://otcshortreport.com/index.php?index=GALEW
Investopedia http://www.investopedia.com/markets/stocks/GALEW/?wa=0
(0)
(0)Scroll down for more posts ▼